[CALCULATION OF REGISTRATION FEE TitleofEachClassofSecuritiestoBeRegistered AmounttoBe Registered ProposedMaximumgregateOffering (1) Price Amountof RegistrationFee (2) Shares ofmmon Stock, $.001 par value $ 28,750,000 $ 2,049.88 (3) (4) Underwritersmmon Stock Purchase Option 1 option $ 100 $ - Shares ofmmon Stock underlying Underwritersmmon Stock Purchase Option $ 781,250 $] [UNDERWRITINGREEMENT betweenYSTAR BIO-PHARMACEUTICALMPANY and RODMAN & RENSHAW, RepresentativeYSTAR BIO-PHARMACEUTICALMPANY UNDERWRITINGREEMENT New York, New York ___________ __, 2010 Rodman & Renshaw, th 1251 Avenue of the Americas, 20 New York, New York 10020 Ladies and Gentlemen:mpany Representative Underwriters Underwriter 1. Purchase andle of Securities.] [Form of Representatives Optionreement THE REGISTERED HOLDER OF THIS PURCHASE OPTION BY ITS ACCEPTANCE HEREOF,REES THAT IT WILL NOT SELL, TRANSFER ORSIGN THIS PURCHASE OPTION EXCEPT HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE OPTIONREES THAT IT WILL NOT SELL, TRANSFER,SIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE OPTION FOR A PERIOD OF ONE HUNDRED EIGHTYYS] [RICHARDSON & PATEL 10900 Wilshire Boulevard Suite 500 Los Angeles,lifornia 90024 Telephone (310) 208-1183 Facsimile (310) 208-1154 ___________________, 2010YSTAR BIO-PHARMACEUTICALMPANY Rm. 10601, Jiezuo Plaza, No.4, Fenghui Road South, Gaoxin District, Xian Province, P.R. China Re:YSTAR BIO-PHARMACEUTICALMPANY Ladies and Gentlemen: Innnection with this opinion, we have examined originals orpies of the registration statement, the proceedings of] [Consent of Independent Registered Public Accounting Firm To the Board of Directorsystar Bio-Pharmaceuticalmpany Wensent to the use of our reportted March 31, 2010, with respect to thensolidated financial statements ofystar Bio-Pharmaceuticalmpany and Subsidiaries (thempany) of December 31, 2009 and 2008 and for the related statements ofome and othermprehensiveome, shareholders equity andsh flows for each of]